Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial
Grinsztejn, Beatriz, MD, Hosseinipour, Mina C, MD, Ribaudo, Heather J, PhD, Swindells, Susan, MBBS, Eron, Joseph, MD, Chen, Ying Q, PhD, Wang, Lei, PhD, Ou, San-San, MS, Anderson, Maija, MN, McCauley, Marybeth, MPH, Gamble, Theresa, PhD, Kumarasamy, Nagalingeshwaran, MB, Hakim, James G, MD, Kumwenda, Johnstone, FRCP, Pilotto, Jose H S, MD, Godbole, Sheela V, MD, Chariyalertsak, Suwat, MD, de Melo, Marineide Gonçalves, MD, Mayer, Kenneth H, MD, Eshleman, Susan H, MD, Piwowar-Manning, Estelle, MT, Makhema, Joseph, FRCP, Mills, Lisa A, MD, Panchia, Ravindre, MBBCh, Sanne, Ian, MBBCh, Gallant, Joel, MD, Hoffman, Irving, PA, Taha, Taha E, MBBS, Nielsen-Saines, Karin, MD, Celentano, David, ScD, Essex, Max, DVM, Havlir, Diane, MD, Cohen, Myron S, Dr
Published in The Lancet infectious diseases (01.04.2014)
Published in The Lancet infectious diseases (01.04.2014)
Get full text
Journal Article